Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rezolute, Inc. - Common Stock (NV) (NQ:RZLT)

2.830 -0.190 (-6.29%)
Streaming Delayed Price Updated: 2:34 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 542,217
Open 2.910
Bid (Size) 2.820 (3)
Ask (Size) 2.830 (8)
Prev. Close 3.020
Today's Range 2.710 - 2.970
52wk Range 2.220 - 6.186
Shares Outstanding 57,943,066
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors
From Rezolute, Inc.
Via GlobeNewswire
Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Performance

YTD
-45.0%
-45.0%
1 Month
-31.6%
-31.6%
3 Month
-45.0%
-45.0%
6 Month
-39.9%
-39.9%
1 Year
+23.6%
+23.6%

More News

Read More
Rezolute Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update
From Rezolute, Inc.
Via GlobeNewswire
Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
From Rezolute, Inc.
Via GlobeNewswire
Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference
From Rezolute, Inc.
Via GlobeNewswire
Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
From Rezolute, Inc.
Via GlobeNewswire
Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
From Rezolute, Inc.
Via GlobeNewswire
FDA Grants Orphan Drug Designation to Rezolute’s Ersodetug (RZ358) for the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
From Rezolute, Inc.
Via GlobeNewswire
Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update
From Rezolute, Inc.
Via GlobeNewswire
Rezolute to Participate in Upcoming Investor Conferences
From Rezolute, Inc.
Via GlobeNewswire
Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update
From Rezolute, Inc.
Via GlobeNewswire
FDA Gives Green Signal To Rezolute's Genetic Disorder Treatment
Via Benzinga
Exposures Product Safety
FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 Study
From Rezolute, Inc.
Via GlobeNewswire
Rezolute to Participate in Upcoming Investor Conferences
From Rezolute, Inc.
Via GlobeNewswire
Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
From Rezolute, Inc.
Via GlobeNewswire
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
From Rezolute, Inc.
Via GlobeNewswire
Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
From Rezolute, Inc.
Via GlobeNewswire
Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds
From Rezolute, Inc.
Via GlobeNewswire
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Adobe, Avidity Biosciences And 3 Stocks To Watch Heading Into Friday
Via Benzinga
RH Posts Mixed Q1 Results, Joins MSC Industrial Direct And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Rezolute, Inc. - Common Stock (NV) publicly traded?
Yes, Rezolute, Inc. - Common Stock (NV) is publicly traded.
What exchange does Rezolute, Inc. - Common Stock (NV) trade on?
Rezolute, Inc. - Common Stock (NV) trades on the Nasdaq Stock Market
What is the ticker symbol for Rezolute, Inc. - Common Stock (NV)?
The ticker symbol for Rezolute, Inc. - Common Stock (NV) is RZLT on the Nasdaq Stock Market
What is the current price of Rezolute, Inc. - Common Stock (NV)?
The current price of Rezolute, Inc. - Common Stock (NV) is 2.830
When was Rezolute, Inc. - Common Stock (NV) last traded?
The last trade of Rezolute, Inc. - Common Stock (NV) was at 04/03/25 02:34 PM ET
What is the market capitalization of Rezolute, Inc. - Common Stock (NV)?
The market capitalization of Rezolute, Inc. - Common Stock (NV) is 163.98M
How many shares of Rezolute, Inc. - Common Stock (NV) are outstanding?
Rezolute, Inc. - Common Stock (NV) has 164M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.